Author:
Shah Kavina,Porter Andrew,Takhar Gagandeep,Reddy Venkat
Abstract
This report highlights the importance of tailored treatment strategies in severe systemic lupus erythematosus (SLE) flares driving the life-threatening condition, macrophage activation syndrome (MAS). We report the case of a 42-year-old woman with active systemic lupus erythematosus (SLE) who was diagnosed with MAS within 3 days of onset of lethargy, rash, joint pain and significant cytopenias. This early diagnosis meant that her condition was managed with less intensive immunosuppression with only modest doses of steroids and mycophenolate mofetil.
Reference12 articles.
1. Macrophage cytokines: involvement in immunity and infectious diseases;Duque;Front Immunol,2014
2. Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis;Behrens;J Rheumatol,2007
3. Clinical features of macrophage activation syndrome as the onset manifestation of juvenile systemic lupus erythematosus;Sato;Rheumatol Adv Pract,2019
4. Macrophage activation syndrome (MAS) in a recently released prisoner with systemic lupus erythematosus (SLE);Szulawski;Am J Case Rep,2018
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献